These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21699874)

  • 1. Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability.
    Malik M; Zhang J; Johannesen L; Hnatkova K; Garnett C
    Heart Rhythm; 2011 Nov; 8(11):1777-85. PubMed ID: 21699874
    [No Abstract]   [Full Text] [Related]  

  • 2. Thoroughly measuring the QT interval: can we find the shortcuts?
    Kowey PR
    Heart Rhythm; 2011 Nov; 8(11):1786-7. PubMed ID: 21762671
    [No Abstract]   [Full Text] [Related]  

  • 3. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thorough QT studies and indirect causes of QTc changes.
    Malik M; Stockbridge N
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1411-2. PubMed ID: 23035657
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation/attenuation of the QRST complexes and their effects on the QT/QTc: a heretofore overlooked important association.
    Madias JE
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1409-10. PubMed ID: 23036086
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation.
    Sadanaga T; Sadanaga F; Yao H; Fujishima M
    Am J Cardiol; 2004 Mar; 93(6):772-5. PubMed ID: 15019891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical issues including design and sample size calculation in thorough QT/QTc studies.
    Zhang J; Machado SG
    J Biopharm Stat; 2008; 18(3):451-67. PubMed ID: 18470755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculations in thorough QT studies.
    Zhang L; Dmitrienko A; Luta G
    J Biopharm Stat; 2008; 18(3):468-82. PubMed ID: 18470756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for positive control activity in a thorough QTc study.
    Zhang J
    J Biopharm Stat; 2008; 18(3):517-28. PubMed ID: 18470760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ANOVA to estimate inter- and intra-reader variability for a group of readers in thorough QT/QTc studies.
    Natekar M; Mahajan V; Satra A; O'Kelly M; Karnad DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):489-91. PubMed ID: 18183035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation testing in thorough QT/QTc clinical trials.
    Tsong Y; Zhong J; Chen WJ
    J Biopharm Stat; 2008; 18(3):529-41. PubMed ID: 18470761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guest editors' notes on statistical issues in design and analysis of thorough QTc studies.
    Tsong Y; Zhang J
    J Biopharm Stat; 2008; 18(3):405-7. PubMed ID: 18470752
    [No Abstract]   [Full Text] [Related]  

  • 15. Choosing tools for QT correction.
    Ehrlich JR
    Heart Rhythm; 2006 Sep; 3(9):1008-9. PubMed ID: 16945791
    [No Abstract]   [Full Text] [Related]  

  • 16. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs.
    Ogunmola OJ; Oladosu YO; Olamoyegun MA
    Ann Afr Med; 2015; 14(4):169-76. PubMed ID: 26470741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysis.
    Agin MA; Aronstein WS; Ferber G; Geraldes MC; Locke C; Sager P
    J Biopharm Stat; 2008; 18(3):408-26. PubMed ID: 18470753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of baseline measurement on the change from baseline in QTc intervals.
    Tian H; Natarajan J
    J Biopharm Stat; 2008; 18(3):542-52. PubMed ID: 18470762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.